Apidra Aventis Pharmaceuticals Inc. - Treatment for Diabetes MellitusApidra is a recombinant DNA human insulin analogue that has a more rapid onset and a shorter duration of action than regular human insulin. Apidra is used for the control of hyperglycemia in adult patients with diabetes mellitus.
Posted: April 2004
- FDA Approves Apidra SoloSTAR - a Prefilled Disposable Insulin Pen - February 26, 2009
- FDA Approves Rapid-Acting Insulin Apidra for Treatment of Children with Diabetes - October 29, 2008
- FDA Approves New Route of Administration for Rapid-Acting Apidra Providing an Additional Treatment Option for Hospitalized Diabetes Patients with High Blood Sugar Levels - June 15, 2007
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.